These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25428645)

  • 1. Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?
    Shaw CA; Li D; Tomljenovic L
    Immunotherapy; 2014; 6(10):1055-71. PubMed ID: 25428645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants.
    Masson JD; Crépeaux G; Authier FJ; Exley C; Gherardi RK
    J Inorg Biochem; 2018 Apr; 181():87-95. PubMed ID: 29307441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system.
    Gherardi RK; Crépeaux G; Authier FJ
    Autoimmun Rev; 2019 Jul; 18(7):691-705. PubMed ID: 31059838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations.
    Tomljenovic L; Shaw CA
    Lupus; 2012 Feb; 21(2):223-30. PubMed ID: 22235057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods to Prepare Aluminum Salt-Adjuvanted Vaccines.
    Thakkar SG; Cui Z
    Methods Mol Biol; 2017; 1494():181-199. PubMed ID: 27718194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?
    Tomljenovic L; Shaw CA
    J Inorg Biochem; 2011 Nov; 105(11):1489-99. PubMed ID: 22099159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aluminum vaccine adjuvants: are they safe?
    Tomljenovic L; Shaw CA
    Curr Med Chem; 2011; 18(17):2630-7. PubMed ID: 21568886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity.
    Shaw CA; Tomljenovic L
    Immunol Res; 2013 Jul; 56(2-3):304-16. PubMed ID: 23609067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An aluminium adjuvant in a vaccine is an acute exposure to aluminium.
    Exley C
    J Trace Elem Med Biol; 2020 Jan; 57():57-59. PubMed ID: 31561170
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine adjuvants.
    Macy DW
    Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):206-11. PubMed ID: 9283246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminum adjuvant dose guidelines in vaccine formulation for preclinical evaluations.
    Vecchi S; Bufali S; Skibinski DA; O'Hagan DT; Singh M
    J Pharm Sci; 2012 Jan; 101(1):17-20. PubMed ID: 21918987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aluminum as an adjuvant in vaccines and post-vaccine reactions].
    Fiejka M; Aleksandrowicz J
    Rocz Panstw Zakl Hig; 1993; 44(1):73-80. PubMed ID: 8235346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine.
    Nøkleby H
    Expert Rev Vaccines; 2007 Oct; 6(5):863-9. PubMed ID: 17931164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physico-chemical properties of aluminum adjuvants in vaccines: Implications for toxicological evaluation.
    Badran G; Angrand L; Masson JD; Crépeaux G; David MO
    Vaccine; 2022 Aug; 40(33):4881-4888. PubMed ID: 35810062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of C-reactive protein as an inflammatory biomarker in rabbits for vaccine nonclinical safety studies.
    Destexhe E; Prinsen MK; van Schöll I; Kuper CF; Garçon N; Veenstra S; Segal L
    J Pharmacol Toxicol Methods; 2013; 68(3):367-73. PubMed ID: 23624216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognition and behavior in sheep repetitively inoculated with aluminum adjuvant-containing vaccines or aluminum adjuvant only.
    Asín J; Pascual-Alonso M; Pinczowski P; Gimeno M; Pérez M; Muniesa A; de Pablo-Maiso L; de Blas I; Lacasta D; Fernández A; de Andrés D; Reina R; Luján L
    J Inorg Biochem; 2020 Feb; 203():110934. PubMed ID: 31783216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reviewing the association between aluminum adjuvants in the vaccines and autism spectrum disorder.
    Boretti A
    J Trace Elem Med Biol; 2021 Jul; 66():126764. PubMed ID: 33930617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants.
    Miyaji EN; Carvalho E; Oliveira ML; Raw I; Ho PL
    Braz J Med Biol Res; 2011 Jun; 44(6):500-13. PubMed ID: 21584443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aluminium adjuvant exposure through vaccines in France in 2018].
    Angrand L; Elnar AA; Authier FJ; Gherardi RK; Crépeaux G
    Ann Pharm Fr; 2020 Mar; 78(2):111-128. PubMed ID: 32081303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.